View Older Stories View More Recent Stories

Mar 31, 2015 10:55AM Roth Places RGS Energy (RGSE) 'Under Review' Ahead of Q4, FY14 Report

Mar 31, 2015 09:16AM Synta Pharma (SNTA) Prices 22M Common Offering at $1.75/Share

Mar 31, 2015 06:00AM RMG Networks Reports Fourth Quarter and Year End 2014 Results

Mar 30, 2015 12:50PM Roth Capital Downgrades Hyperion Therapeutics (HPTX) to Neutral

Mar 30, 2015 12:22PM UPDATE: Can-Fite BioPharma's (CANF) CF101 Phase 2/3 Missed Primary Endpoint; Roth Downgrades to Neutral

Mar 30, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 3/30: (MGA) (YELP) (AAPL) (BBRY)

Mar 30, 2015 11:55AM Lion Biotechnologies (LBIO) Receives First External Validation of Phase I TIL/Yervoy in Metastatic Melanoma; Roth Capital Affirms at 'Buy'

Mar 30, 2015 10:41AM Roth Affirms Ligand (LGND) at 'Buy' Following Amgen (AMGN), Spectrum (SPPI) Updates

Mar 30, 2015 08:56AM Roth Capital Downgrades Superior Drilling Products (SDPI) to Neutral

Mar 27, 2015 06:51AM Roth Capital Downgrades FutureFuel Corp. (FF) to Neutral

Mar 26, 2015 10:54AM SolarEdge Technologies (SEDG) IPO Opens Up 11%

Mar 26, 2015 10:39AM ROTH Capital Partners Expands Banking Practice with the Addition of David T. Farina, CFA as a Managing Director, Investment Banking

Mar 26, 2015 10:21AM Roth Comments on Galena's (GALE) Expanded NeuVax, Trastuzumab Enrollments; Affirms 'Buy' Rating

Mar 26, 2015 09:00AM SolarEdge Technologies, Inc. Announces Pricing of Its Initial Public Offering

Mar 26, 2015 08:30AM Low ASPs, Higher Operating Expenses Push Yingli Green Energy (YGE) to Wider-than-Expected Q4 Loss - Roth

Mar 26, 2015 07:29AM Roth Capital Starts Argos Therapeutics (ARGS) at Buy

Mar 25, 2015 09:45AM BioLineRx's (BLRX) BL-8040 Better Positioned as SOC Alternate in SC Mobilization - Roth Capital

Mar 25, 2015 08:44AM RMG Networks (RMGN) Announces $25M Conv. Preferred Offering

Mar 25, 2015 08:30AM RMG Networks Raises $25 Million in Private Placement of Convertible Preferred Stock

Mar 25, 2015 08:04AM Mad Catz (MCZ) Enters 8.98M Common, 4.49M Warrants Direct Offering

Mar 25, 2015 08:01AM Mad Catz® Announces $3.7 Million Registered Direct Offering

Mar 24, 2015 04:01PM Concert Pharmaceuticals Announces Completion of Public Offering

Mar 24, 2015 02:12PM GenVec (GNVC) FY14 Results Flat with Views; Hearing Loss Phase I Update Encouraging - Roth Capital

Mar 23, 2015 02:03PM PRESERVATION I Study is Key Upcoming Milestone for BioLineRx (BLRX); Roth Affirms at 'Buy'

Mar 23, 2015 11:39AM Can-Fite Bio Pharma's (CANF) CF101 Receives Additional Validation with Latest Agreement - Roth

Mar 23, 2015 10:45AM Notable Analyst Rating Changes 3/23: (SPLS) (ELY) (NMM) Upgraded; (NVDA) (CCL) (SHW) Downgraded

Mar 23, 2015 10:20AM UPDATE: Roth Capital Downgrades MEI Pharma (MEIP) to Neutral; Future of Pracinostat Now in Question

Mar 23, 2015 08:08AM Bluebird Bio (BLUE) PT Raised to $145 at Roth Capital

Mar 19, 2015 09:24AM Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share

Mar 19, 2015 09:00AM Concert Pharmaceuticals Announces Pricing of Public Offering

Mar 18, 2015 04:35PM Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

Mar 18, 2015 04:35PM Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

Mar 18, 2015 02:51PM MLP Benefit Likely $3 to $6/Share for Green Plains (GPRE); Roth Affirms at 'Buy'

Mar 18, 2015 10:46AM Can-Fite BioPharma (CANF) Reaches Important Milestone; Psoriasis Data Expected Soon - Roth

Mar 18, 2015 06:46AM Roth Capital Downgrades RSP Permian, Inc. (RSPP) to Neutral

Mar 18, 2015 06:26AM Amid Plug Power's (PLUG) Achievements, More Gross Margin Improvement Needed; Roth Trims PT to $2.60

Mar 17, 2015 02:08PM Roth Affirms Rexahn (RNN) at 'Buy' Following FY14 Results; Supinoxin, RX-3117 Remain in Focus

Mar 17, 2015 12:41PM Roth Affirms Celldex (CLDX) at 'Focus Pick'; Solidifying Itself as Premier Cancer Immunotherapy Company

Mar 17, 2015 10:33AM Roth Trims PT on Nuverra Environmental Solutions (NES) to $3.50; Asset, Labor Utilization Showing Improvement

Mar 17, 2015 09:53AM UPDATE: Roth Capital Downgrades Dynamic Materials (BOOM) to Neutral

Mar 17, 2015 09:20AM Roth Capital Reinstates Conatus Pharmaceuticals (CNAT) at Buy

Mar 17, 2015 09:04AM Rexahn Pharma (RNN) Reports Wider Loss for 2014; Updates on Clinical Development Programs

Mar 17, 2015 09:00AM Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Pipeline Update

Mar 16, 2015 02:02PM Roth Affirms Spectrum Pharma (SPPI) at 'Neutral'; Focus Remains on Pipeline Advancement

Mar 13, 2015 02:10PM COSMIC-HF Phase 2 Reaches Important Milestone; Roth Affirms Cytokinetics (CYTK) at 'Buy'

Mar 13, 2015 09:34AM JA Solar (JASO) Capacity Expansion Remains on Track; Roth Capital Affirms 'Buy' Rating

Mar 13, 2015 09:24AM Galena Biopharma (GALE) Prices 24.4M Common, Warrants Offering at $1.56/Unit

Mar 13, 2015 09:22AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

Mar 13, 2015 09:22AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

Mar 11, 2015 10:15AM Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants

View More Recent Stories View Older Stories